| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Income (loss) before income tax expense | -203,036 | 107,454 | 519,846 | -122,332 |
| Income tax expense (benefit) | -657 | 946 | 1,200 | -1,032 |
| Net income (loss) | -202,379 | 106,508 | 518,646 | -121,300 |
| Basic (in shares) | 162,353,000 | 162,019,000 | 161,049,000 | 160,049,000 |
| Basic (in usd per share) | -1.25 | 0.66 | 3.22 | -0.76 |
| Diluted (in shares) | 162,353,000 | 177,215,000 | 177,625,000 | 160,049,000 |
| Diluted (in usd per share) | -1.25 | 0.62 | 2.93 | -0.76 |
NOVAVAX INC (NVAX)
NOVAVAX INC (NVAX)